Genetic Predisposition clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Pancreatic Cancer Early Detection Consortium
open to eligible people ages 18-90
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
at UCSD UCSF
Our lead scientists for Genetic Predisposition research studies include Margaret Tempero,, MD Andy Lowy Joy Liau.